Nearly half of all clinical trials still use paper as the primary – or even sole – source of records while barely a quarter of trials use eCOA or ePRO. 

One leading eCOA executive said that the problem for adoption among sites, sponsors, and eCOA leaders may simply a failure to communicate, "We still have issues with misaligned expectations between sponsors and sites as to how to make eCOA successful."